Lotilaner Ophthalmic Solution, 0.25%, for the Treatment of Demodex Blepharitis: Results of a Prospective, Randomized, Vehicle-Controlled, Double-Masked, Pivotal Trial (Saturn-1)

Cornea
August 10, 2022
Cited by 48


Related Papers

No related papers found

Powered by citation graph analysis